BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 289370)

  • 21. [Which factors influence skeletal metastases of breast cancer?].
    Biersack HJ; Frommhold H; Breuel HP; Winkler C
    Med Klin; 1980 Aug; 75(18):663-4. PubMed ID: 6252426
    [No Abstract]   [Full Text] [Related]  

  • 22. [Value of skeletal scintigraphy in the therapy of breast cancer].
    Köhler AH; Weidig W
    Zentralbl Chir; 1982; 107(22):1433-9. PubMed ID: 7164627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of pretreatment bone scans in breast carcinoma.
    Komaki R; Donegan W; Manoli R; Yeh EL
    AJR Am J Roentgenol; 1979 Jun; 132(6):877-81. PubMed ID: 108963
    [No Abstract]   [Full Text] [Related]  

  • 24. Skeletal scintigraphy in carcinoma of the breast.
    Br Med J; 1977 Sep; 2(6087):592-3. PubMed ID: 901990
    [No Abstract]   [Full Text] [Related]  

  • 25. [Complex x-ray-radioisotope study in the diagnosis of bone metastases of breast cancer].
    Sanchakova AV; Chernomordikova MF; Tret'iakova OI; Fadeev NP
    Vestn Rentgenol Radiol; 1979; (3):17-23. PubMed ID: 462750
    [No Abstract]   [Full Text] [Related]  

  • 26. [The importance of bone scintigraphy in the pretherapeutic development of mammary neoplasm (author's transl)].
    Baudoux A; Beauduin M; Hermans J; Pluygers E
    Inter Des; 1979; 62(1):29-33. PubMed ID: 10243918
    [No Abstract]   [Full Text] [Related]  

  • 27. [Staging of patients with carcinoma of the breast by bone scans? [author's transl)].
    Creutzig H
    Radiologe; 1978 May; 18(5):179-83. PubMed ID: 652985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Should systematic bone scintigraphy be carried out on breast cancer patients with small tumors?].
    Lagrange JL; Frenay M; Darcourt J; François E; Héry M; Namer M; Lapalus F
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(6):701-8. PubMed ID: 2258588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone scintigraphy screening in stage I-II breast cancer: is it cost-effective?
    Wikenheiser KA; Silberstein EB
    Cleve Clin J Med; 1996; 63(1):43-7. PubMed ID: 8590515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic value of diffuse skull activity in bone scintigraphy from breast cancer patients.
    Hale TI; Jucker A
    Eur J Nucl Med; 1987; 13(2):106-7. PubMed ID: 3609053
    [No Abstract]   [Full Text] [Related]  

  • 31. Is baseline bone imaging in high-risk breast cancer patients justified?
    Ampil FL; Li BD; Burton GV; Kim RH; Baluna RG; Chu Q
    Breast J; 2012; 18(6):639-40. PubMed ID: 23009654
    [No Abstract]   [Full Text] [Related]  

  • 32. [Scintigraphy in breast cancer].
    Morita R; Fukunaga M; Otsuka N
    Gan No Rinsho; 1986 Jan; Suppl():163-76. PubMed ID: 3959327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The value of bone marrow scintigraphy in patients with recurrent breast cancer].
    Langer SW; Kamby C; Thomsen HS; Sørensen T; Hvid-Jacobsen K; Dombernowsky P; Nielsen SL
    Ugeskr Laeger; 1993 Mar; 155(11):778-82. PubMed ID: 8460428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance of bone scintigraphy for early detection of bone metastasis from breast cancer].
    Wada T; Hohjoh T; Matunami N; Yamato M; Kadota K; Morikawa E; Hara S; Matsuda T; Yasutomi M
    Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):781-5. PubMed ID: 2778373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indications for bone scans in preoperative evaluation of breast cancer.
    Clark DG; Painter RW; Sziklas JJ
    Am J Surg; 1978 May; 135(5):667-70. PubMed ID: 646040
    [No Abstract]   [Full Text] [Related]  

  • 36. The clinical use of staging bone scan in patients with breast carcinoma: reevaluation by the 2003 American Joint Committee on Cancer staging system.
    Lee JE; Park SS; Han W; Kim SW; Shin HJ; Choe KJ; Oh SK; Youn YK; Noh DY; Kim SW
    Cancer; 2005 Aug; 104(3):499-503. PubMed ID: 15968691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bone metastases in breast cancer and its risk factor--follow up study by bone scintigraphy].
    Tanaka S; Matsumura Y; Tanaka M; Okamura T; Oda J; Ochi H; Onoyama Y; Morimoto K; Nakatani M; Fujimoto M
    Kaku Igaku; 1991 Oct; 28(10):1177-80. PubMed ID: 1800779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Whole-body bone scintigraphy in the diagnosis and follow-up of the evolution of breast cancer].
    Muşat E; Stefănescu C; Rusu V
    Rev Med Chir Soc Med Nat Iasi; 1999; 103(1-2):163-9. PubMed ID: 10756905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bone scintigraphy in oncology, when is it appropriate?].
    Schütte HE; Pauwels EK
    Ned Tijdschr Geneeskd; 1985 Mar; 129(10):459-62. PubMed ID: 2984590
    [No Abstract]   [Full Text] [Related]  

  • 40. Bone metastases in primary operable breast cancer. The role of a yearly scintigraphy.
    Thomsen HS; Rasmussen D; Munck O; Lund JO; Gerhard-Nielsen V; Terkildsen T; Dombernowsky P; Andersen KW
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):779-81. PubMed ID: 3115785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.